TrialBreast cancer research : BCR2014

Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients.

Ryuji Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.